Reduction in duodenal endocrine cells in irritable bowel syndrome is associated with stem cell abnormalities

doi:10.3748/wjg.v21.i32.9577

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 32

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7028)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series.

Item

Count

PDF

437

WORD

348

HTML

3291

Figures (1-6)

149

Sum=4225

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

966

Download

1837

Sum=2803

Aug 28, 2015 (publication date) through Apr 18, 2024

Times Cited of This Article

Times Cited (22)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Control Study

World J Gastroenterol. Aug 28, 2015; 21(32): 9577-9587
Published online Aug 28, 2015. doi: 10.3748/wjg.v21.i32.9577

Full Size Figure Download Figure

Figure 6 Cholecystokinin-immunoreactive cells (arrows) in (A) a control subject (B) irritable bowel syndrome-D, (C) irritable bowel syndrome-M and (D) irritable bowel syndrome-C patients.

Citation: El-Salhy M, Hatlebakk JG, Hausken T. Reduction in duodenal endocrine cells in irritable bowel syndrome is associated with stem cell abnormalities. World J Gastroenterol 2015; 21(32): 9577-9587
URL: https://www.wjgnet.com/1007-9327/full/v21/i32/9577.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i32.9577